This content is restricted.
Brief
"On October 21, 2024, the National Administration of Drugs, Food and Medical Technology (ANMAT) issued an update regarding Public Consultation on New Pharmacopoeia Monographs Launched. The ANMAT announced that the following monographs from the Argentine Pharmacopeia are available for public consultation: DESLORATADINA, NITRATO DE MICONAZOL, ESPIROLACTONA, and ESPIROLACTONA COMPRIMIDOS."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested